1. Home
  2. JBL vs RDY Comparison

JBL vs RDY Comparison

Compare JBL & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBL
  • RDY
  • Stock Information
  • Founded
  • JBL 1966
  • RDY 1984
  • Country
  • JBL United States
  • RDY India
  • Employees
  • JBL N/A
  • RDY N/A
  • Industry
  • JBL Electrical Products
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • JBL Technology
  • RDY Health Care
  • Exchange
  • JBL Nasdaq
  • RDY Nasdaq
  • Market Cap
  • JBL 14.1B
  • RDY 13.1B
  • IPO Year
  • JBL 1993
  • RDY N/A
  • Fundamental
  • Price
  • JBL $128.24
  • RDY $14.30
  • Analyst Decision
  • JBL Buy
  • RDY Buy
  • Analyst Count
  • JBL 7
  • RDY 1
  • Target Price
  • JBL $143.50
  • RDY $17.00
  • AVG Volume (30 Days)
  • JBL 1.1M
  • RDY 770.6K
  • Earning Date
  • JBL 12-12-2024
  • RDY 11-05-2024
  • Dividend Yield
  • JBL 0.25%
  • RDY 4.04%
  • EPS Growth
  • JBL 85.55
  • RDY 4.63
  • EPS
  • JBL 11.17
  • RDY 0.76
  • Revenue
  • JBL $28,883,000,000.00
  • RDY $3,579,112,656.00
  • Revenue This Year
  • JBL N/A
  • RDY $13.39
  • Revenue Next Year
  • JBL $5.60
  • RDY $8.35
  • P/E Ratio
  • JBL $11.50
  • RDY $18.83
  • Revenue Growth
  • JBL N/A
  • RDY 12.37
  • 52 Week Low
  • JBL $95.85
  • RDY $12.90
  • 52 Week High
  • JBL $156.94
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • JBL 51.94
  • RDY 35.66
  • Support Level
  • JBL $126.06
  • RDY $13.97
  • Resistance Level
  • JBL $129.36
  • RDY $15.19
  • Average True Range (ATR)
  • JBL 2.73
  • RDY 0.26
  • MACD
  • JBL -0.94
  • RDY -0.05
  • Stochastic Oscillator
  • JBL 26.47
  • RDY 22.57

About JBL Jabil Inc.

Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: